Celldex (CLDX)

0.59 +0.01 (1.72%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/4/18 *Est.)

Latest Headlines

Form 4 Celldex Therapeutics, For: Jun 15 Filed by: KELER TIBOR June 18, 2018 8:15 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Heath-Chiozzi Margo June 15, 2018 7:58 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Martin Samuel Bates June 15, 2018 7:53 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Cavanaugh Sarah June 15, 2018 7:53 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Crowley Elizabeth June 15, 2018 7:50 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Wright Richard M. June 15, 2018 7:48 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: PEPIN RONALD June 15, 2018 7:47 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: KELER TIBOR June 15, 2018 7:43 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Marucci Anthony S June 15, 2018 7:40 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Brownlie Keith L June 15, 2018 7:37 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: MARINO JAMES J June 15, 2018 7:35 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: McMahon Gerald PhD June 15, 2018 7:34 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: CONRAD HERBERT J June 15, 2018 7:31 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: ELLBERGER LARRY June 15, 2018 7:28 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: PENNER HARRY JR June 15, 2018 7:27 AM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 13 Filed by: Shoos Karen L. June 15, 2018 7:26 AM - SEC Filing Form 8-K Celldex Therapeutics, For: Jun 13 June 14, 2018 4:02 PM - SEC Filing Form 4 Celldex Therapeutics, For: Jun 01 Filed by: McMahon Gerald PhD June 4, 2018 8:16 AM - SEC Filing Celldex (CLDX) Highlights Promising Data from Phase 1/2 Study of Varlilumab and Opdivo June 4, 2018 6:59 AM - StreetInsider Celldex Presents Promising Data from Phase 1/2 Study of Varlilumab and Opdivo® at 2018 ASCO Annual Meeting June 2, 2018 4:12 PM - Globe NewsWire Celldex Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference June 1, 2018 11:30 AM - Globe NewsWire Form 8-K Celldex Therapeutics, For: May 29 June 1, 2018 8:01 AM - SEC Filing Celldex Therapeutics (CLDX) PT Lowered to $2.15 at H.C. Wainwright May 17, 2018 11:33 AM - StreetInsider Celldex (CLDX) Announces Presentations at ASCO May 16, 2018 5:07 PM - StreetInsider Celldex Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting May 16, 2018 5:01 PM - Globe NewsWire Form SC 13G/A Celldex Therapeutics, Filed by: FMR LLC May 10, 2018 10:51 AM - SEC Filing Form 10-Q Celldex Therapeutics, For: Mar 31 May 10, 2018 8:21 AM - SEC Filing Form 8-K Celldex Therapeutics, For: May 10 May 10, 2018 8:01 AM - SEC Filing Celldex Provides Corporate Update and Reports First Quarter 2018 Results May 10, 2018 8:00 AM - Globe NewsWire Form 4 Celldex Therapeutics, For: May 01 Filed by: McMahon Gerald PhD May 2, 2018 7:16 AM - SEC Filing Form DEF 14A Celldex Therapeutics, For: Jun 13 April 30, 2018 9:01 AM - SEC Filing Form 8-K Celldex Therapeutics, For: Apr 24 April 24, 2018 4:02 PM - SEC Filing Form CT ORDER Celldex Therapeutics, April 20, 2018 11:04 AM - SEC Filing Celldex (CLDX) Says Data from Multiple Programs Presented at AACR April 20, 2018 8:07 AM - StreetInsider Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018 April 20, 2018 8:01 AM - Globe NewsWire Form PRE 14A Celldex Therapeutics, For: Jun 13 April 19, 2018 4:05 PM - SEC Filing UPDATE: Cantor Fitzgerald Downgrades Celldex Therapeutics (CLDX) to Neutral, 'Glemba in Rear View Mirror' April 17, 2018 4:06 AM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $1 at Jefferies; 'METRIC PIII Trial Fails' April 17, 2018 3:07 AM - StreetInsider Cowen Downgrades Celldex Therapeutics (CLDX) to Market Perform April 16, 2018 1:02 PM - StreetInsider Celldex Therapeutics (CLDX) PT Lowered to $2.50 at H.C. Wainwright April 16, 2018 10:54 AM - StreetInsider Pre-Open Stock Movers 04/16: (ERI) (ALKS) (DVAX) Higher; (CLDX) (ALGT) (NLNK) Lower (more...) April 16, 2018 9:23 AM - StreetInsider Celldex (CLDX) Set to Open Lower By 49% After METRIC Study Fails April 16, 2018 8:24 AM - StreetInsider Celldex (CLDX) Announces Phase 2B METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint April 16, 2018 7:04 AM - StreetInsider Form 8-K Celldex Therapeutics, For: Apr 16 April 16, 2018 7:01 AM - SEC Filing Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint April 16, 2018 7:00 AM - Globe NewsWire Form 4 Celldex Therapeutics, For: Apr 02 Filed by: McMahon Gerald PhD April 3, 2018 7:52 AM - SEC Filing Full Article List